Patents by Inventor Junmei Wang

Junmei Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF CHAETOMIUM GLOBOSUM STRAIN IN CONTROLLING FUSARIUM CROWN ROT OF WHEAT
    Publication number: 20220053771
    Abstract: The present disclosure provides use of a Chaetomium globosum strain in controlling Fusarium crown rot (FCR) of wheat. The C. globosum strain under the deposit designation of 12XP1-2-3 is deposited at China General Microbiological Culture Collection Center (CGMCC) on Jan. 23, 2019 with an accession number of CGMCC No. 17183. Field experiments conclude that coating of wheat seeds with Chaetomium globosum strain 12XP1-2-3 can reduce diseased stem rate, disease rating, and disease index by 19.0%-41.3%, 43.7%, and 4.7%-45.4%, respectively.
    Type: Application
    Filed: April 19, 2021
    Publication date: February 24, 2022
    Inventors: Fei Xu, Yuli Song, Junmei Wang, Jiaojiao Zhang, Zixing Han, Yahong Li, Ruijie Shi, Lijuan Li, Lulu Liu
  • ISOLATE OF CHAETOMIUM GLOBOSUM AND ITS APPLICATION IN WHEAT GROWTH PROMOTION AND YIELD INCREASE
    Publication number: 20220056399
    Abstract: This invention provides an isolate of Chaetomium globosum, which is numbered as 12XP1-2-3, preserved by China General Microbiological Culture Collection Center with CGMCC No. 17183 on Jan. 23, 2019. This invention also provides an application of Chaetomium globosum in wheat growth promotion and yield increase. The results of field trials showed that by coating wheat seeds with Chaetomium globosum 12XP1-2-3, the chlorophyll content of leaves can be increased by 1.9%-14.7% at booting stage, and the wheat yield can be increased by 2.3%-10.9%.
    Type: Application
    Filed: July 6, 2021
    Publication date: February 24, 2022
    Inventors: Yuli SONG, Fei XU, Junmei WANG, Zixing HAN, Yahong LI, Chaohong FENG
  • USE OF HISTONE MODIFIERS TO REPROGRAM EFFECTOR T CELLS
    Publication number: 20210189337
    Abstract: The present disclosure provides methods for re-programming effector T cells to a central memory phenotype comprising culturing the effector T cells with a histone deacetylase inhibitor (HDACi) and IL-21. Further provided are methods of treating cancer comprising administering the central memory T cells.
    Type: Application
    Filed: March 28, 2019
    Publication date: June 24, 2021
    Applicant: Board of Regents, The University of Texas System
    Inventors: Cassian YEE, Junmei WANG
  • Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
    Patent number: 7265122
    Abstract: The present invention relates to urotensin II receptor antagonists, pharmaceutical compositions containing them and their use.
    Type: Grant
    Filed: February 20, 2004
    Date of Patent: September 4, 2007
    Assignee: Encysive Pharmaceuticals, Inc.
    Inventors: Chengde Wu, C. Eric Anderson, Huong Bui, Brian Dupre, Daxin Gao, George W. Holland, Jamal Kassir, Wen Li, Junmei Wang
  • Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
    Publication number: 20050054850
    Abstract: The present invention relates to urotensin II receptor antagonists, pharmaceutical compositions containing them and their use.
    Type: Application
    Filed: August 23, 2004
    Publication date: March 10, 2005
    Inventors: Chengde Wu, C. Anderson, Huong Bui, Brian Dupre, Daxin Gao, George Holland, Jamal Kassir, Wen Li, Junmei Wang
  • Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonists
    Publication number: 20050049286
    Abstract: The present invention relates to urotensin II receptor antagonists, CCR-9 antagonists, pharmaceutical compositions containing them and their use.
    Type: Application
    Filed: August 23, 2004
    Publication date: March 3, 2005
    Inventors: Chengde Wu, C. Anderson, Huong Bui, Daxin Gao, Jamal Kassir, Wen Li, Junmei Wang, Ronald Biediger, Jie Chen, Robert Market
  • Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
    Publication number: 20040186102
    Abstract: The present invention relates to urotensin II receptor antagonists, pharmaceutical compositions containing them and their use.
    Type: Application
    Filed: February 20, 2004
    Publication date: September 23, 2004
    Inventors: Chengde Wu, C. Eric Anderson, Huong Bui, Brian Dupre, Daxin Gao, George W. Holland, Jamal Kassir, Wen Li, Junmei Wang
  • Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonists
    Publication number: 20040180892
    Abstract: The present invention relates to urotensin II receptor antagonists, CCR-9 antagonists, pharmaceutical compositions containing them and their use.
    Type: Application
    Filed: February 18, 2004
    Publication date: September 16, 2004
    Applicant: Encysive Pharmaceuticals Inc.
    Inventors: Chengde Wu, C. Eric Anderson, Huong Bui, Daxin Gao, Jamal Kassir, Wen Li, Junmei Wang, Robert V. Market